A targeted therapy for melanoma by graphene oxide composite with microRNA carrier

BACKGROUND: Nowadays, the combination of microRNA (miR) is attracting increased attention in clinical cancer trials. However, the clinical use of miR is highly limited because of certain properties such as instability, low-specificity distribution, and metabolic toxicity. METHODS: In order to improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Can, Xie, Huiqing, Yu, Jingang, Chen, Xiaoqing, Tang, Shijie, Sun, Lichun, Chen, Xiang, Peng, Defei, Zhang, Xiangyan, Zhou, Jianda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157538/
https://www.ncbi.nlm.nih.gov/pubmed/30275686
http://dx.doi.org/10.2147/DDDT.S160088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157538/
https://www.ncbi.nlm.nih.gov/pubmed/30275686
http://dx.doi.org/10.2147/DDDT.S160088

Ejemplares similares